Hong Kong, China

Tak-Hang Chan

This inventor holds 20 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Polyphenol Synthesis. Top assignees: The Hong Kong Polytechnic University, Mcgill University, University of South Florida. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tak-Hang Chan. Retrieved from https://idiyas.com/inventor/tak-hang-chan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 75.0


Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Montreal, CA (2008 - 2016)
  • Hong Kong, CN (2009 - 2021)
  • Toronto, CA (2014 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Prodrug
Epigallocatechin
Endometriosis
Ionic Tags
Oligoribonucleotides
Polyphenol
Proteasome Inhibitors
Pyrimidines
Flavonoid Dimers
Ionic Liquids
Synthesis
Bacterial Infections
20 patents (USPTO):Explore Patents

Title: Tak-Hang Chan: Innovator in Biotechnology

Introduction

Tak-Hang Chan, based in Hong Kong, CN, is an accomplished inventor with a remarkable portfolio of 20 patents. His innovations primarily focus on biotechnological advancements, particularly in the fields of medicinal chemistry and oligonucleotide synthesis. His work has contributed significantly to modern therapeutics.

Latest Patents

Among his latest patents is a groundbreaking development involving a prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG), designed for the treatment of endometriosis. This invention details methods of treating endometriosis and related indications by administering Pro-EGCG, which is a synthetic derivative product of epigallocatechin-3-gallate. Additionally, his research includes the use of Pro-EGCG in the manufacture of medicaments aimed at treating endometriosis.

Tak-Hang Chan has also made strides in the field of chemical synthesis with his patent on ionic tags for the synthesis of oligoribonucleotides. This invention relates to the chemical synthesis of oligonucleotides, particularly oligoribonucleotides, and includes processes for making compounds that facilitate this synthesis. The methods presented also extend to the synthesis of oligomers, which includes oligopeptides, oligosaccharides, and oligonucleotides.

Career Highlights

Tak-Hang Chan has had a notable career, contributing his expertise to prestigious institutions such as The Hong Kong Polytechnic University and McGill University. His academic and research endeavors have propelled advancements in biotechnology and medicinal chemistry.

Collaborations

Throughout his career, Tak-Hang Chan has collaborated with esteemed colleagues, including Larry Ming-Cheung Chow and Q Ping Dou. Their combined efforts have fostered significant innovations in their respective fields.

Conclusion

With 20 patents to his name, Tak-Hang Chan’s contributions to biotechnology and medicinal chemistry are profound. His innovative approaches to treating complex medical conditions and advancing chemical synthesis techniques position him as a notable figure in the realm of scientific invention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…